Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Johnson & Johnson presents potential novel approach to treat diabetes and obesity

Sep. 1, 2011

New gamma-secretase modulator shows promise in Alzheimer's disease models

Sep. 1, 2011

GABA-AT inhibitor shows promise to treat epilepsy and drug addiction

Sep. 1, 2011

Clinical data presented on doxazosin/dutasteride in men with benign prostatic hyperplasia

Aug. 31, 2011

Gilead discloses data on HCV NS3 inhibitor

Aug. 31, 2011

Novel inhibitors of chemokine CCR2/CCR5 receptors described

Aug. 31, 2011

First-in-class agent lowers blood pressure in patients with heart failure

Aug. 31, 2011

Brain-penetrant inhibitor of kynurenine aminotransferase II described by Pfizer

Aug. 30, 2011

Additional analyses of AVERROES study presented

Aug. 30, 2011

Pfizer describes discovery and investigation of AMPA receptor modulator now in phase I

Aug. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...